GLP-1 prior authorization: a telehealth provider research checklist

01

Prior authorization is one step in a larger coverage chain

HealthCare.gov defines prior authorization as health-plan approval that may be required before a service or prescription is covered. That definition is intentionally narrower than many clinic advertisements. It does not mean the plan approved the medical decision, that every claim will be paid, or that the patient's final cost is known.

Separate at least four questions: whether the telehealth clinician can evaluate and prescribe; whether the visit is in network or reimbursable; whether the exact drug is on the formulary for the stated use; and whether the dispensing pharmacy and claim meet the plan's rules. Each can have a different answer.

A telehealth provider may prescribe an FDA-approved GLP-1 product, offer a compounded product, or discuss both. Prior authorization generally concerns plan coverage for a covered benefit. Approval for one named product and indication does not approve a compounded substitute, another brand, another formulation, or an off-label use.

02

Define what the clinic actually handles

Ask who owns each task. Some services verify benefits, some submit an initial electronic request, some respond to plan questions, and some prepare medical-necessity statements or appeals. Others give the patient a template and call that prior-authorization support. None of these scopes should be inferred from a badge on a pricing page.

Identify the prescribing medical practice and clinician, not only the platform brand. Confirm that the clinician is licensed for the state where the patient is located and can access the records required by the plan. Ask whether a different staff member, contractor, or software vendor handles insurance information and how secure messages are exchanged.

Get the service terms in writing: initial submission, expected follow-up, resubmission after missing information, renewal, formulary changes, denial review, appeal, and record transfer. Ask what happens if the clinician concludes the requested product is not appropriate; payment for a membership should never predetermine a prescription.

• →Benefits verification
• →Initial request
• →Responses to plan questions
• →Renewal timing
• →Denial and appeal support
• →Records transfer after cancellation

03

Verify coverage directly with the health plan

Use the member portal or number on the insurance card and ask about the exact drug, strength or presentation when relevant, indication, prescribing clinician, pharmacy network, and effective date. HHS advises verifying telehealth coverage ahead of appointments because commercial coverage varies; telehealth-service coverage and pharmacy-benefit coverage remain separate.

Request the current formulary entry and utilization-management criteria. Plans may use prior authorization, step therapy, quantity limits, or indication-specific coverage. Medicare's public guidance illustrates these distinct categories, but a Medicare rule should not be generalized to an employer or marketplace plan.

Ask whether the clinic and its laboratory are in network, whether the medication claim runs through pharmacy or medical benefits, and whether manufacturer savings programs or cash prices affect deductible or out-of-pocket accounting. The clinic should not promise a final cost unless the relevant payer and claim pathway have confirmed it.

04

Build a dated authorization file

Keep the plan criteria, formulary page, authorization number, submission date, decision, expiration date, renewal window, and every request for information. Save the clinic invoice and program terms separately from insurance documents. A portal status such as pending or submitted is not a plan approval letter.

The prescriber may need accurate medical records to support a request. Provide records through an approved secure channel, not ordinary email or a public support form. Never alter a diagnosis, date, measurement, prior treatment history, or other clinical fact to fit criteria. A clinic that suggests doing so is creating a safety, ethics, and fraud concern.

Ask how the clinic will notify you of missing information and whether delays trigger another membership charge. Document who will monitor renewal deadlines and whether the clinic continues support after a formulary change. Coverage can end even when a prior request succeeded previously.

05

A denial, exception, and appeal are not interchangeable

A denied prior authorization can result from missing information, failure to meet a criterion, a nonformulary product, a coverage exclusion, a network or pharmacy issue, or an administrative error. Obtain the written reason and appeal instructions before deciding the next step. Do not rely on a clinic's paraphrase when the plan notice is available.

Medicare drug guidance distinguishes coverage determinations, exceptions, and appeals and states that prescriber support may be required. It also publishes deadlines and expedited pathways for qualifying circumstances. Those rules are useful examples, not universal deadlines; commercial, Medicaid, employer, and demonstration-program processes differ.

Ask whether the clinic will correct an error, submit additional documentation, request an exception, or pursue an appeal—and whether each is included in the quoted fee. A provider cannot guarantee the outcome. Treatment alternatives, interruptions, or urgency require a clinical conversation, not an insurance strategy improvised by a customer-service agent.

06

Compare fees, exits, and warning signs before paying

Map every payer: platform membership, medical-practice visit, laboratory, pharmacy, and insurer cost sharing. Ask whether the membership starts before coverage is decided, whether a denial changes the fee, whether refunds are possible, and how to cancel recurring charges. A fee for administrative work may be nonrefundable even if the plan denies coverage, but that must be disclosed clearly before purchase.

Warning signs include guaranteed approval, guaranteed copay, using “insurance accepted” without naming the billed service, charging for an appeal that was advertised as included, refusing to provide the denial, steering every denied patient to a compounded cash product, or asking the patient to misstate medical facts. Also be cautious when the dispensing pharmacy is not disclosed until after payment.

The best comparison is operational: who is licensed, what gets billed, what work is included, how records are secured, what happens after denial, and how care continues if the subscription ends. That evidence is more useful than a success-rate claim with no denominator, plan mix, date, or independent audit.

• →No approval or cost guarantees
• →Exact entities and fees disclosed
• →Plan criteria checked directly
• →Written denial and appeal access
• →Secure records handling
• →Clear cancellation and continuity process